Prelude Capital Management’s Outset Medical OM Stock Holding History

Prelude Capital Management’s Portfolio OM Stock Details OM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,364	Closed	-$223K	–	1269
2023 Q3	$223K	Buy	+1,364	New	+$322K	0.01%	836
2023 Q1	–	Sell	-628	Closed	-$243K	–	1380
2022 Q4	$243K	Buy	+628	New	+$177K	0.01%	888
2022 Q1	–	Sell	-533	Closed	-$369K	–	2113
2021 Q4	$369K	Hold	533	–	–	0.01%	1197
2021 Q3	$396K	Buy	533 +200	+60%	+$136K	0.01%	1016
2021 Q2	$250K	Buy	+333	New	+$255K	0.01%	1283

Other funds holding OM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

MIC

Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return

Prelude Capital Management's OM Position: Q4 2023 in Review

Prelude Capital Management sold out of Outset Medical (OM) in Q4 2023, closing a stake of 1,364 shares — an estimated $223K sold.

Prelude Capital Management first reported a position in OM in Q2 2021 and held it in 5 quarters. The position peaked at $396K in Q3 2021. 140 funds tracked by Wall St. Rank hold OM as of Q4 2023.

Prelude Capital Management reported no remaining Outset Medical position as of Q4 2023 after selling out during the quarter.
Prelude Capital Management sold 1,364 Outset Medical shares in Q4 2023, an estimated $223K.
Prelude Capital Management first reported a position in Outset Medical in Q2 2021 and held it in 5 quarters.
Prelude Capital Management's Outset Medical position peaked at $396K in Q3 2021.
140 funds tracked by Wall St. Rank held Outset Medical as of Q4 2023.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.